PolyPeptide Group AG
SIX:PPGN

Watchlist Manager
PolyPeptide Group AG Logo
PolyPeptide Group AG
SIX:PPGN
Watchlist
Price: 27.75 CHF -3.65%
Market Cap: CHf919.4m

Gross Margin

12.5%
Current
Improving
by 2.7%
vs 3-y average of 9.9%

Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.

Gross Margin
12.5%
=
Gross Profit
€43.1m
/
Revenue
€370.5m

Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.

Gross Margin
12.5%
=
Gross Profit
CHf43.1m
/
Revenue
€370.5m

Peer Comparison

Country Company Market Cap Gross
Margin
CH
PolyPeptide Group AG
SIX:PPGN
950.2m CHF
Loading...
US
PerkinElmer Inc
LSE:0KHE
1.2T USD
Loading...
US
Thermo Fisher Scientific Inc
NYSE:TMO
230.9B USD
Loading...
US
Danaher Corp
NYSE:DHR
160.2B USD
Loading...
KR
Samsung Biologics Co Ltd
KRX:207940
82.4T KRW
Loading...
CH
Lonza Group AG
SIX:LONN
36.5B CHF
Loading...
US
IQVIA Holdings Inc
NYSE:IQV
40.7B USD
Loading...
CN
WuXi AppTec Co Ltd
SSE:603259
274.9B CNY
Loading...
US
Agilent Technologies Inc
NYSE:A
38B USD
Loading...
US
Mettler-Toledo International Inc
NYSE:MTD
28.7B USD
Loading...
US
Illumina Inc
NASDAQ:ILMN
23.1B USD
Loading...

Market Distribution

Lower than 90% of companies in Switzerland
Percentile
10th
Based on 957 companies
10th percentile
12.5%
Low
-13 700% — 34.9%
Typical Range
34.9% — 65.3%
High
65.3% — 137.7%
Distribution Statistics
Switzerland
Min -13 700%
30th Percentile 34.9%
Median 49.4%
70th Percentile 65.3%
Max 137.7%

PolyPeptide Group AG
Glance View

PolyPeptide Group AG is a contract development and manufacturing organization for clinical and approved commercial-stage peptide drug substances used in peptide-based therapeutics. The company is headquartered in Zug, Zug and currently employs 1,041 full-time employees. The company went IPO on 2021-04-29.

PPGN Intrinsic Value
23.23 CHF
Overvaluation 16%
Intrinsic Value
Price
What is Gross Margin?
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
How is Gross Margin calculated?

Gross Margin is calculated by dividing the Gross Profit by the Revenue.

Gross Margin
12.5%
=
Gross Profit
€43.1m
/
Revenue
€370.5m
What is PolyPeptide Group AG's current Gross Margin?

The current Gross Margin for PolyPeptide Group AG is 12.5%, which is above its 3-year median of 9.9%.

How has Gross Margin changed over time?

Over the last 3 years, PolyPeptide Group AG’s Gross Margin has decreased from 31.9% to 12.5%. During this period, it reached a low of 2.2% on Jun 30, 2023 and a high of 31.9% on Jun 30, 2022.

Back to Top